My watch list  

Tumor hypoxia

Tumor hypoxia is the situation where tumor cells have been deprived of oxygen. Hypoxic tumor cells usually resist to radiotherapy and chemotherapy [1] as they can be made more susceptible to treatment by increasing the amount of oxygen in them, but bioreductive prodrugs play a significant part in dealing with this kind of cells: they can kill the oxygen-deficient tumor cells selectively as hypoxic cytotoxins. Study of tumors in such conditions was pioneered by Dr L. H. Gray.

It can also be a result of the high degree of cell proliferation undergone in tumor tissue, causing a higher cell density, and thus taxing the local oxygen supply.

See also


    1. ^ W. A. Denny, Prodrug strategies in cancer therapy, Eur. J. Med. Chem., 2001, 36, 577–595

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Tumor_hypoxia". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE